For many patients, digestive side effects like heartburn and nausea are most intense during the first few weeks of treatment or after a dosage increase
For a type 2 diabetic patient currently taking metformin, pioglitazone, dapagliflozin, basal insulin glargine, prandial insulin lispro, and sitagliptin, which glucagonlike peptide1 (GLP1) receptor agonist should be selected?
By activating the GLP-1 receptor, retatrutide is thought to help reduce appetite, slow gastric emptying, and improve insulin secretion in a glucose-dependent manner
Semaglutide works best when injected once weekly because the medication maintains consistent levels in your bloodstream that trigger appetite-suppressing signals in your brain
There are several reasons why someone might choose to take GLP drugs, ranging from goals such as weight loss and improved heart health, to medical conditions like type 2 diabetes
British Journal of Dermatology, 97, 247-254